Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arylsulfatase A (ARSA) is a lysosomal enzyme responsible for the degradation of sulfatides, particularly cerebroside 3-sulfate. It is essential for maintaining myelin integrity in the nervous system. Deficiency in ARSA leads to the accumulation of sulfatides, causing metachromatic leukodystrophy (MLD). ARSA activity is assayed to diagnose MLD, and therapies are being developed to restore ARSA function.
Hydrolysis of cerebroside 3-sulfate into cerebroside and sulfate. Phosphate can act as an inhibitor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arylsulfatase A (ARSA).